Properties of granules that contain kallikrein and renin.
D000438:Alcohols / Q000494:pharmacology; D000447:Aldehydes / Q000494:pharmacology; D000804:Angiotensin II / Q000378:metabolism; D000818:Animals; D001120:Arginine / Q000378:metabolism; D001565:Benzoates / Q000378:metabolism; D002499:Centrifugation, Density Gradient; D002501:Centrifugation, Zonal; D003594:Cytoplasmic Granules / Q000201:enzymology*; D004950:Esterases / Q000378:metabolism; D004952:Esters / Q000378:metabolism; D006868:Hydrolysis; D007610:Kallikreins / Q000378:metabolism*; D007705:Kinins / Q000378:metabolism; D008297:Male; D008566:Membranes / Q000187:drug effects; D051379:Mice; D012083:Renin / Q000378:metabolism*; D013053:Spectrophotometry; D013363:Submandibular Gland / Q000166:cytology / Q000201:enzymology; D013395:Sucrose
D000438:Alcohols; D000447:Aldehydes; D001565:Benzoates; D004952:Esters; D007705:Kinins; D000804:Angiotensin II; D013395:Sucrose; D001120:Arginine; D004950:Esterases; D007610:Kallikreins; D012083:Renin